Safety of Dexamphetamine in Acute Ischemic Stroke

Completed

Phase N/A Results

Summary of Purpose

To evaluate the safety and tolerablility of dexamphetamine in acute ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 May 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Federation of County Councils, Family Janne Elgqvist foundation, Swedish Association of Neurologically Disabled, Ake Wiberg Foundation, Karolinksa Institute, Swedish Stroke Association

Trial Design

Randomized, double-blind, controlled dose-escalation trial.

Contacts

Not available